Current Protein Identity:Q01166 New Search
Main Difference Dimensions in This Set
Different construct Different ligand/ion Different experimental conditions Different structure-quality metrics

Difference tags compare only the current result set; every original PDB and assembly record remains separate.

Related-Structure Differences

Each row represents one biological assembly in one PDB entry; multiple monomers of the same protein are listed separately.

PDB Entry Assembly / Oligomeric State Construct Mutations and Modifications Ligands, Ions and Non-polymers Experimental Method Experimental Conditions Structure Quality
8IWV Crystal structure of BlaA-1 APO Deposited 2023-03-31 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–294(294 aa)
Not recorded PO4 PHOSPHATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 8.5;293 K;0.1 M TRIS hydrochloride pH 8.5, 2.0 M Ammonium phosphate monobasic
Resolution 2.40 Å R-free 0.235
9VGV Crystal Structure of BlaA beta-lactamase in complex with the Antifungal Agent Tavaborole. Deposited 2025-06-15 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 34–294(261 aa)
Not recorded A1CF8 Tavaborole × 1 CL CHLORIDE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;0.1 M TRIS hydrochloride pH 8.5, 2.0 M Ammonium phosphate monobasic
Resolution 2.50 Å R-free 0.269
9XFW Crystal structure of Class A beta-lactamase BlaA in complex with Meropenem (Imine form) Deposited 2025-10-29 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–294(294 aa)
Not recorded DWZ (2S,3R,4S)-4-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-2-[(2S,3R)-3-hydroxy-1-oxobutan-2-yl]-3-methyl-3,4-dihydro-2H-pyrrole-5-carboxylic acid × 1 PO4 PHOSPHATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 8.5;293 K;0.1 M TRIS hydrochloride pH 8.5, 2.0 M Ammonium phosphate monobasic
Resolution 2.00 Å R-free 0.271
9XFX Crystal structure of Class A beta-lactamase BlaA in complex with Tebipenem (imine form) Deposited 2025-10-29 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–294(294 aa)
Not recorded A1MCI TEBIPENEM, BOUND FORM × 1 EDO 1,2-ETHANEDIOL × 1 PO4 PHOSPHATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 8.5;293 K;0.1 M TRIS hydrochloride pH 8.5, 2.0 M Ammonium phosphate monobasic
Resolution 1.50 Å R-free 0.204
9XFY Crystal structure of Class A beta-lactamase BlaA in complex with ertapenem (imine form) Deposited 2025-10-29 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–294(294 aa)
Not recorded 2RG (2S,3R,4S)-4-({(3S,5S)-5-[(3-carboxyphenyl)carbamoyl]pyrrolidin-3-yl}sulfanyl)-2-[(1S,2R)-1-formyl-2-hydroxypropyl]-3-methyl-3,4-dihydro-2H-pyrrole-5-carboxylic acid × 1 PO4 PHOSPHATE ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 8.5;293 K;0.1 M TRIS hydrochloride pH 8.5, 2.0 M Ammonium phosphate monobasic
Resolution 1.70 Å R-free 0.230